Clinical trial
[18]F-FAZA PET Imaging Study in Patients With Cancer of the Head & Neck, Lung…
NCT00323076 · AHS Cancer Control Alberta, Other · Terminated
Key facts
| NCT number | NCT00323076 |
|---|---|
| Title | [18]F-FAZA PET Imaging Study in Patients With Cancer of the Head & Neck, Lung, Renal Cell, Brain, Lymphoma and Neuroendocrine Tumours |
| Official title | A Phase I/II Imaging Study of 1-a-D-(5-deoxy-5-[18]F-fluoroarabinofuranosyl)-2-nitroimidazole ([18]F-FAZA) in Patients With Known Squamous Cell Carcinoma of the Head & Neck, Small Cell and Non-Small Cell Carcinoma of the Lung, Lymphoma, Glioblastoma Multiforme, Neuroendocrine Tumours or Renal Cell… |
| Lead sponsor | AHS Cancer Control Alberta, Other |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Renal Cell Carcinoma, Neuroendocrine Tumours |
| Intervention type | Drug |
| Interventions | 18F-FAZA PET Imaging |
| Enrollment | 92 |
| Start date | Sep 12, 2006 |
| Primary completion | Feb 4, 2019 |
| Completion | Feb 4, 2019 |
| First posted | May 9, 2006 |
| Last update posted | Aug 26, 2019 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: